# CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

> **NCT06708299** · PHASE3 · RECRUITING · sponsor: **Cardiol Therapeutics Inc.** · enrollment: 110 (estimated)

## Conditions studied

- Recurrent Pericarditis

## Interventions

- **DRUG:** CardiolRx

## Key facts

- **NCT ID:** NCT06708299
- **Lead sponsor:** Cardiol Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-07
- **Primary completion:** 2026-09-21
- **Final completion:** 2026-10-21
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06708299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06708299, "CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06708299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*